Isodicentric/pseudoisodicentric chromosome 21 amplification in four cases of acute myelocytic leukemia or myelodysplasia

Cancer Genetics and Cytogenetics

Volumn 138, Issue 1, 2002, Pages 80-84

  Viguié, Franck ^a,e   Aboura, Azzedine ^a,b   Bouscary, Didier ^c   Guesnu, Martine ^c   Baumelou, Elisabeth ^d   Dreyfus, François ^c   Casadevall, Nicole ^a   Tachdjian, Gérard ^b  

^a HÔTEL DIEU   (France)

^b HÔPITAL ANTOINE BÉCLÈRE   (France)

^c Hôpital Cochin ^*  (France)

^d FOCH HOSPITAL   (France)

^e Lab de Cytogenetique H   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BONE MARROW; CASE REPORT; CHROMOSOME 21; CHROMOSOME 5Q; CHROMOSOME ABERRATION; GENE AMPLIFICATION; GENE LOCUS; HUMAN; KARYOTYPE; MALE; MYELODYSPLASIA; PRIORITY JOURNAL; PROGNOSIS; TRISOMY 21;

AGED; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 21; CORE BINDING FACTOR ALPHA 2 SUBUNIT; DNA-BINDING PROTEINS; GENE AMPLIFICATION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PROTO-ONCOGENE PROTEINS; TRANSCRIPTION FACTORS;

EID: 0036806018     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(02)00580-0     Document Type: Article

References (16)

1. Mitelman F., Heim S., Mandahl N. Trisomy 21 in neoplastic cells. Am J Med Genet. 7(Suppl):1990;262-266.
2. Cortes J.E., Kantarjian H., O'Brien S., Keating M., Pierce S., Freireich E.J., Estey E. Clinical and prognostic significance of trisomy 21 in adult patients with acute myelogenous leukemia and myelodysplastic syndromes. Leukemia. 9:1995;115-117.
3. Wan T.S., Au W.Y., Chan J.C., Chan L.C., Ma S.K. Trisomy 21 as the sole acquired karyotypic abnormality in acute myeloid leukemia and myelodysplastic syndrome. Leuk Res. 23:1991;1079-1083.
4. Touw I., Donath J., Pouwels K., van Buitenen C., Schipper P., Santini V., Hagemeijer A., Löwenberg B., Delwel R. Acute myeloid leukemias with chromosomal abnormalities involving the 21q22 region identified by their in vitro responsiveness to interleukin-5. Leukemia. 5:1991;687-692.
5. Sankar M., Tanaka K., Arif M., Shintani T., Kumaravel T.S., Kyo T., Dohy H., Kamada N. Isodicentric chromosome 21. a novel aberration in acute myeloid leukemia Cancer Genet Cytogenet. 107:1998;69-72.
6. Viguié F. +21 or trisomy 21. Atlas Genet Cytogenet Oncol Haema-tol. URL: http://www.infobiogen.fr/services/chromcancer/Anomalies/tri21ID1041.htmll; 2001.
7. Cowell J.K., Miller O.J. Occurrence and evolution of homogeneously staining regions may be due to breakage-fusion-bridge cycles following telomere loss. Chromosoma. 88:1983;216-221.
8. Kakazu N., Taniwaki M., Horiike S., Nishida K., Tatekawa T., Nagai M., Takahashi T., Akaogi T., Inazawa J., Ohki M., Abe T. Combined spectral karyotyping and DAPI banding analysis of chromosome abnormalities in myelodysplastic syndrome. Genes Chromosomes Cancer. 26:1999;336-345.
9. Heller A, Chudoba I, Bleck C, Senger G, Claussen U, Liehr T. Microdissection based comparative genomic hybridization analysis (micro-CGH) of secondary acute myelogenous leukemias. Int J Oncol 16:461-8.
10. Streubel B., Valent P., Lechner K., Fonatsch C. Amplification of the AML1 (CBFA2) gene on ring chromosomes in a patient with acute myeloid leukemia and a constitutional ring chromosome 21. Cancer Genet Cytogenet. 124:2001;42-46.
11. Andersen MK, Pedersen-Bjergaard J. Increased frequency of dicentric chromosomes in therapy-related MDS and AML compared to de novo disease is significantly related to previous treatment with alkylating agents and suggests a specific susceptibility to chromosome breakage at the centromere. Leukemia 14:105-111.
12. Mori P.G., Haupt R., Fugazza G., Sessarego M., Corcione A., Strigini P., Sansome R. Pentasomy 21 in leukemia complicating Diamond-Blackfan anemia. Cancer Genet Cytogenet. 63:1992;70-72.
13. Huret J.L., Schoenwald M., Gabarre J., Vaugier G.L., Tanzer J. Two additional cases of isochromosome 21q or translocation 21q21q in hematological malignancies. Acta Haematol. 86:1991;111-114.
14. Busson-Le Coniat M., Nguyen Khac F., Daniel M.-T., Bernard O.A., Berger R. Chromosome 21 abnormalities with AML1 amplification in acute lymphoblastic leukemia. Genes Chromosomes Cancer. 32:2001;244-249.
15. Dal Cin P., Atkins L., Ford C., Ariyanayagam S., Armstrong S.A., George R., Cleary A., Morton C.C. Amplification of AML1 in childhood acute lymphoblastic leukemias. Genes Chromosomes Cancer. 30:2001;407-409.
16. Preudhomme C., Warot-Loze D., Roumier C., Grardel-Duflos N., Garand R., Lai J.L., Dastugue N., Macintyre E., Denis C., Bauters F., Kerckaert J.P., Cosson A., Fenaux P. High incidence of biallelic point mutations in the Runt domain of the AML1/PEB2αB gene in Mo acute myeloid leukemia and in myeloid malignancies with acquired trisomy 21. Blood. 96:2000;2862-2869.